🎯 check Darovasertib (LXS196) product page
Darovasertib (LXS196) is a potent, selective PKC inhibitor. It affects PKC signaling, by blocking kinase activity, inhibiting uveal melanoma (UM) progression, and is safely evaluated in combination with crizotinib.